Deutsche Bank Ag\ Organogenesis Holdings Inc. Transaction History

Deutsche Bank Ag\

$262 Billion
Q2 2025

A detailed history of Deutsche Bank Ag\ transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 3,277,949 shares of ORGO stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,277,949

Previous 2,441,902 34.24%

Holding current value

$14.8 Million

Previous $10.5 Million 13.73%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$2.66 - $5.34 $2.22 Million - $4.46 Million	836,047 Added 34.24%	3,277,949 $12 Million
Q1 2025 May 09, 2025	SELL	$2.89 - $6.21 $22,926 - $49,263	-7,933 Reduced 0.32%	2,441,902 $10.5 Million
Q4 2024 Jun 30, 2025	BUY	$2.77 - $4.43 $21,974 - $35,143	7,933 Added 0.32%	2,449,835 $7.84 Million
Q4 2024 Feb 14, 2025	SELL	$2.77 - $4.43 $6.63 Million - $10.6 Million	-2,393,857 Reduced 49.42%	2,449,835 $7.84 Million
Q3 2024 Jun 26, 2025	BUY	$2.42 - $3.24 $5.81 Million - $7.78 Million	2,401,790 Added 98.36%	4,843,692 $13.9 Million
Q3 2024 Nov 13, 2024	BUY	$2.42 - $3.24 $5.66 Million - $7.58 Million	2,339,633 Added 93.43%	4,843,692 $13.9 Million
Q2 2024 Jun 12, 2025	BUY	$2.28 - $3.03 $141,717 - $188,335	62,157 Added 2.55%	2,504,059 $7.01 Million
Q2 2024 Aug 14, 2024	SELL	$2.28 - $3.03 $14,012 - $18,622	-6,146 Reduced 0.24%	2,504,059 $7.01 Million
Q1 2024 Jun 02, 2025	BUY	$2.61 - $4.49 $178,270 - $306,680	68,303 Added 2.8%	2,510,205 $7.13 Million
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $3,186 - $5,482	-1,221 Reduced 0.05%	2,510,205 $7.13 Million
Q4 2023 Feb 14, 2024	BUY	$1.97 - $4.21 $4.87 Million - $10.4 Million	2,474,444 Added 6690.94%	2,511,426 $10.3 Million
Q3 2023 Nov 09, 2023	SELL	$2.34 - $4.43 $736,589 - $1.39 Million	-314,782 Reduced 89.49%	36,982 $117,000
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $33,719 - $76,312	-17,747 Reduced 4.8%	351,764 $1.17 Million
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $3,713 - $5,757	1,965 Added 0.53%	369,511 $787,000
Q4 2022 Feb 13, 2023	BUY	$2.48 - $3.43 $33,561 - $46,418	13,533 Added 3.82%	367,546 $988,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $32,455 - $66,460	-10,336 Reduced 2.84%	354,013 $1.15 Million
Q2 2022 Aug 11, 2022	SELL	$4.74 - $8.15 $7,105 - $12,216	-1,499 Reduced 0.41%	364,349 $1.78 Million
Q1 2022 May 13, 2022	SELL	$6.47 - $9.57 $170,956 - $252,868	-26,423 Reduced 6.74%	365,848 $2.79 Million
Q4 2021 Feb 11, 2022	SELL	$9.02 - $13.5 $104,595 - $156,546	-11,596 Reduced 2.87%	392,271 $3.63 Million
Q3 2021 Nov 04, 2021	SELL	$13.71 - $17.18 $578,959 - $725,494	-42,229 Reduced 9.47%	403,867 $5.75 Million
Q2 2021 Aug 11, 2021	BUY	$14.92 - $23.23 $5.76 Million - $8.97 Million	386,008 Added 642.4%	446,096 $7.41 Million
Q1 2021 May 13, 2021	BUY	$7.33 - $21.06 $301,966 - $867,587	41,196 Added 218.06%	60,088 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $27,373 - $56,783	7,541 Added 66.43%	18,892 $142,000
Q3 2020 Nov 12, 2020	BUY	$3.29 - $4.58 $3,237 - $4,506	984 Added 9.49%	11,351 $44,000
Q2 2020 Aug 13, 2020	BUY	$2.86 - $4.61 $19,096 - $30,780	6,677 Added 180.95%	10,367 $40,000
Q1 2020 May 14, 2020	SELL	$2.92 - $5.31 $648 - $1,178	-222 Reduced 5.67%	3,690 $12,000
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $4,201 - $7,250	894 Added 29.62%	3,912 $18,000
Q3 2019 Nov 14, 2019	SELL	$3.57 - $8.09 $7,554 - $17,118	-2,116 Reduced 41.22%	3,018 $18,000
Q2 2019 Aug 14, 2019	SELL	$6.58 - $8.69 $64,859 - $85,657	-9,857 Reduced 65.75%	5,134 $39,000
Q1 2019 May 15, 2019	BUY	$7.05 - $150.0 $105,686 - $2.25 Million	14,991 New	14,991 $112,000

Others Institutions Holding ORGO

# of Institutions

121

Shares Held

69.8M

Call Options Held

15.1K

Put Options Held

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $593M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account